Psychometric discrimination of Alzheimer's disease and mild cognitive impairment

被引:0
|
作者
Arnáiz, E [1 ]
Blomberg, M [1 ]
Fernaeus, SE [1 ]
Wahlund, LO [1 ]
Winblad, B [1 ]
Almkvist, O [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Neurosci Occupat Therapy & Elderly Care, Div Geriatr Med, S-14186 Huddinge, Sweden
来源
ALZHEIMERS REPORTS | 2000年 / 3卷 / 02期
关键词
Alzheimer's disease; diagnosis; discriminant analysis; mild cognitive impairment; neuropsychological tests;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mild Cognitive Impairment (MCI) refers to a boundary between normal ageing and dementia. People with MCI have a high risk of developing dementia, frequently Alzheimer's disease (AD). In order to develop a reduced-length psychometric battery, we performed an extended neuropsychological battery of tests on the classification of 94 individuals with AD, 90 individuals clinically diagnosed as MCI, and 79 normal elderly subjects. Using discriminant analysis techniques, it was possible to achieve a high rate of correspondence between clinical and present statistical classification of the three groups (85%). We found that specific ability domains, particularly episodic memory, as well as semantic memory, visuospatial function and attention contributed to the two discriminant functions. The first and dominant discriminant function, which only included five tests, discriminated the three groups according to a global cognitive function. These findings demonstrate the possibility of developing reduced-length cognitive batteries so as to identify MCI in subjects at risk of developing AD.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [21] Taste in mild cognitive impairment and Alzheimer's disease
    Steinbach, Silke
    Hundt, Walter
    Vaitl, Andreas
    Heinrich, Petra
    Foerster, Stefan
    Buerger, Katharina
    Zahnert, Thomas
    JOURNAL OF NEUROLOGY, 2010, 257 (02) : 238 - 246
  • [22] Biomarkers of mild cognitive impairment and Alzheimer's disease
    Tang, Bor Luen
    Kumar, Rajeev
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (05) : 406 - 410
  • [23] Taste in mild cognitive impairment and Alzheimer’s disease
    Silke Steinbach
    Walter Hundt
    Andreas Vaitl
    Petra Heinrich
    Stefan Förster
    Katharina Bürger
    Thomas Zahnert
    Journal of Neurology, 2010, 257 : 238 - 246
  • [24] Mild cognitive impairment: Aging to Alzheimer's disease
    Bieber, MR
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (10): : 1897 - 1898
  • [25] A PET Study of Discrimination of Cerebral Glucose Metabolism in Alzheimer's Disease and Mild Cognitive Impairment
    Sun, Haining
    Hu, Bin
    Yao, Zhijun
    Jackson, Mike
    PROCEEDINGS OF THE 2013 6TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2013), VOLS 1 AND 2, 2013, : 6 - 11
  • [26] Decline of Human Tactile Angle Discrimination in Patients with Mild Cognitive Impairment and Alzheimer's Disease
    Yang, Jiajia
    Ogasa, Takashi
    Ohta, Yasuyuki
    Abe, Koji
    Wu, Jinglong
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (01) : 225 - 234
  • [27] Discrimination of mild cognitive impairment from mild Alzheimer's disease by human in vivo serotonin metabolism exploration
    Truchot, Lydie
    Castes, Nicolas
    Vighetto, Alain
    Laurent, Bernard
    Lebars, Didier
    Thomas-Anterion, Catherine
    Croisile, Bernard
    Mercier, Bernadette
    Zimmer, Luc
    Krolak-Salmon, Pierre
    NEUROLOGY, 2007, 68 (12) : A61 - A61
  • [28] Olfactory discrimination testing correlates with memory impairment in Alzheimer's disease and mild cognitive impairment but not in vascular dementia
    Vyhnalek, M.
    Magerova, H.
    Laczo, J.
    Varjassyova, A.
    Hort, J.
    JOURNAL OF NEUROLOGY, 2008, 255 : 127 - 127
  • [29] Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease
    Adlam, Anna-Lynne R.
    Bozeat, Sasha
    Arnold, Robert
    Watson, Peter
    Hodges, John R.
    CORTEX, 2006, 42 (05) : 675 - 684
  • [30] Quality of life in mild cognitive impairment and mild Alzheimer's disease
    Shin, I. S.
    Kim, J. M.
    Kim, S. W.
    Yoon, J. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S382 - S383